TY - JOUR AU - Pitout, J. D. AU - Laupland, K. B. PY - 2008 DA - 2008// TI - Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern JO - Lancet Infect Dis VL - 8 UR - https://doi.org/10.1016/S1473-3099(08)70041-0 DO - 10.1016/S1473-3099(08)70041-0 ID - Pitout2008 ER - TY - JOUR AU - Medeiros, A. A. PY - 1993 DA - 1993// TI - Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America JO - Ann Intern Med VL - 119 UR - https://doi.org/10.7326/0003-4819-119-5-199309010-00015 DO - 10.7326/0003-4819-119-5-199309010-00015 ID - Medeiros1993 ER - TY - JOUR AU - Doi, Y. AU - Park, Y. S. AU - Rivera, J. I. AU - Adams-Haduch, J. M. AU - Hingwe, A. AU - Sordillo, E. M. PY - 2013 DA - 2013// TI - Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cis942 DO - 10.1093/cid/cis942 ID - Doi2013 ER - TY - JOUR AU - Ben-Ami, R. AU - Rodriguez-Bano, J. AU - Arslan, H. AU - Pitout, J. D. AU - Quentin, C. AU - Calbo, E. S. PY - 2009 DA - 2009// TI - A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients JO - Clin Infect Dis VL - 49 UR - https://doi.org/10.1086/604713 DO - 10.1086/604713 ID - Ben-Ami2009 ER - TY - JOUR AU - Stuart, R. L. AU - Kotsanas, D. AU - Webb, B. AU - Vandergraaf, S. AU - Gillespie, E. E. AU - Hogg, G. G. PY - 2011 DA - 2011// TI - Prevalence of antimicrobial-resistant organisms in residential aged care facilities JO - Med J Aust VL - 195 UR - https://doi.org/10.5694/mja11.10724 DO - 10.5694/mja11.10724 ID - Stuart2011 ER - TY - JOUR AU - Rooney, P. J. AU - O'Leary, M. C. AU - Loughrey, A. C. AU - McCalmont, M. AU - Smyth, B. AU - Donaghy, P. PY - 2009 DA - 2009// TI - Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli JO - J Antimicrob Chemother VL - 64 UR - https://doi.org/10.1093/jac/dkp220 DO - 10.1093/jac/dkp220 ID - Rooney2009 ER - TY - JOUR AU - Chen, Y. H. AU - Hsueh, P. R. AU - Badal, R. E. AU - Hawser, S. P. AU - Hoban, D. J. AU - Bouchillon, S. K. PY - 2011 DA - 2011// TI - Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria JO - J Infect VL - 62 UR - https://doi.org/10.1016/j.jinf.2011.02.009 DO - 10.1016/j.jinf.2011.02.009 ID - Chen2011 ER - TY - JOUR AU - Molton, J. S. AU - Tambyah, P. A. AU - Ang, B. S. AU - Ling, M. L. AU - Fisher, D. A. PY - 2013 DA - 2013// TI - The Global Spread of Healthcare-Associated Multidrug-Resistant Bacteria: A Perspective From Asia JO - Clin Infect Dis VL - 56 UR - https://doi.org/10.1093/cid/cit020 DO - 10.1093/cid/cit020 ID - Molton2013 ER - TY - JOUR AU - Hsu, L. Y. AU - Tan, T. Y. AU - Tam, V. H. AU - Kwa, A. AU - Fisher, D. A. AU - Koh, T. H. PY - 2010 DA - 2010// TI - Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.01076-09 DO - 10.1128/AAC.01076-09 ID - Hsu2010 ER - TY - JOUR AU - Paterson, D. L. AU - Bonomo, R. A. PY - 2005 DA - 2005// TI - Extended-spectrum beta-lactamases: a clinical update JO - Clin Microbiol Rev VL - 18 UR - https://doi.org/10.1128/CMR.18.4.657-686.2005 DO - 10.1128/CMR.18.4.657-686.2005 ID - Paterson2005 ER - TY - JOUR AU - Nicolau, D. P. PY - 2008 DA - 2008// TI - Carbapenems: a potent class of antibiotics JO - Expert Opin Pharmacother VL - 9 UR - https://doi.org/10.1517/14656566.9.1.23 DO - 10.1517/14656566.9.1.23 ID - Nicolau2008 ER - TY - JOUR AU - McLaughlin, M. AU - Advincula, M. R. AU - Malczynski, M. AU - Qi, C. AU - Bolon, M. AU - Scheetz, M. H. PY - 2013 DA - 2013// TI - Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00607-13 DO - 10.1128/AAC.00607-13 ID - McLaughlin2013 ER - TY - JOUR AU - Chang, H. -. J. AU - Hsu, P. -. C. AU - Yang, C. -. C. AU - Kuo, A. -. J. AU - Chia, J. -. H. AU - Wu, T. -. L. PY - 2011 DA - 2011// TI - Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteraemia: A matched case–control study JO - J Microbiol Immunol Infect VL - 44 UR - https://doi.org/10.1016/j.jmii.2010.06.001 DO - 10.1016/j.jmii.2010.06.001 ID - Chang2011 ER - TY - JOUR AU - Armand-Lefevre, L. AU - Angebault, C. AU - Barbier, F. AU - Hamelet, E. AU - Defrance, G. AU - Ruppe, E. PY - 2013 DA - 2013// TI - Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.01823-12 DO - 10.1128/AAC.01823-12 ID - Armand-Lefevre2013 ER - TY - JOUR AU - Nordmann, P. AU - Dortet, L. AU - Poirel, L. PY - 2012 DA - 2012// TI - Carbapenem resistance in Enterobacteriaceae: here is the storm! JO - Trends Mol Med. VL - 18 UR - https://doi.org/10.1016/j.molmed.2012.03.003 DO - 10.1016/j.molmed.2012.03.003 ID - Nordmann2012 ER - TY - STD TI - Glasner C, Albiger B, Buist G, Tambic Andrasevic A, Canton R, Carmeli Y et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro surveill. 2013;18(28). Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20525. UR - http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20525 ID - ref16 ER - TY - JOUR AU - Akova, M. AU - Daikos, G. L. AU - Tzouvelekis, L. AU - Carmeli, Y. PY - 2012 DA - 2012// TI - Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria JO - Clin Microbiol Infect VL - 18 UR - https://doi.org/10.1111/j.1469-0691.2012.03823.x DO - 10.1111/j.1469-0691.2012.03823.x ID - Akova2012 ER - TY - JOUR AU - Perez, F. AU - Bonomo, R. A. PY - 2012 DA - 2012// TI - Can we really use beta-lactam/beta-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum beta-lactamase-producing bacteria? JO - Clin Infect Dis VL - 54 UR - https://doi.org/10.1093/cid/cir793 DO - 10.1093/cid/cir793 ID - Perez2012 ER - TY - JOUR AU - Harris, P. N. AU - Tambyah, P. A. AU - Paterson, D. L. PY - 2015 DA - 2015// TI - beta-lactam and beta-lactamase inhibitor combinations in the treatment of extended-spectrum beta-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? JO - Lancet Infect Dis VL - 15 UR - https://doi.org/10.1016/S1473-3099(14)70950-8 DO - 10.1016/S1473-3099(14)70950-8 ID - Harris2015 ER - TY - JOUR AU - Rodriguez-Bano, J. AU - Navarro, M. D. AU - Retamar, P. AU - Picon, E. AU - Pascual, A. PY - 2012 DA - 2012// TI - Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria G. beta-Lactam/beta-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts JO - Clin Infect Dis VL - 54 UR - https://doi.org/10.1093/cid/cir790 DO - 10.1093/cid/cir790 ID - Rodriguez-Bano2012 ER - TY - JOUR AU - Retamar, P. AU - Lopez-Cerero, L. AU - Muniain, M. A. AU - Pascual, A. AU - Rodriguez-Bano, J. AU - Group, E. -. R. G. PY - 2013 DA - 2013// TI - Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-beta-lactamase-producing Escherichia coli JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00135-13 DO - 10.1128/AAC.00135-13 ID - Retamar2013 ER - TY - JOUR AU - Elm, E. AU - Altman, D. G. AU - Egger, M. AU - Pocock, S. J. AU - Gotzsche, P. C. AU - Vandenbroucke, J. P. PY - 2008 DA - 2008// TI - The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies JO - J Clin Epidemiol VL - 61 UR - https://doi.org/10.1016/j.jclinepi.2007.11.008 DO - 10.1016/j.jclinepi.2007.11.008 ID - Elm2008 ER - TY - STD TI - European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters version 5.0. 2015. www.eucast.org. UR - http://www.eucast.org ID - ref23 ER - TY - JOUR AU - Friedman, N. D. AU - Kaye, K. S. AU - Stout, J. E. AU - McGarry, S. A. AU - Trivette, S. L. AU - Briggs, J. P. PY - 2002 DA - 2002// TI - Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections JO - Ann Intern Med VL - 137 UR - https://doi.org/10.7326/0003-4819-137-10-200211190-00007 DO - 10.7326/0003-4819-137-10-200211190-00007 ID - Friedman2002 ER - TY - JOUR AU - Charlson, M. AU - Szatrowski, P. AU - Peterson, J. AU - Gold, J. PY - 1994 DA - 1994// TI - Validation of a combined comorbidity index JO - J Clin Epidemiol VL - 47 UR - https://doi.org/10.1016/0895-4356(94)90129-5 DO - 10.1016/0895-4356(94)90129-5 ID - Charlson1994 ER - TY - JOUR AU - Knaus, W. A. AU - Draper, E. A. AU - Wagner, D. P. AU - Zimmerman, J. E. PY - 1985 DA - 1985// TI - APACHE II: a severity of disease classification system JO - Crit Care Med VL - 13 UR - https://doi.org/10.1097/00003246-198510000-00009 DO - 10.1097/00003246-198510000-00009 ID - Knaus1985 ER - TY - JOUR AU - Paterson, D. L. AU - Ko, W. C. AU - Gottberg, A. AU - Mohapatra, S. AU - Casellas, J. M. AU - Goossens, H. PY - 2004 DA - 2004// TI - International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections JO - Ann Intern Med VL - 140 UR - https://doi.org/10.7326/0003-4819-140-1-200401060-00008 DO - 10.7326/0003-4819-140-1-200401060-00008 ID - Paterson2004 ER - TY - JOUR AU - Vardakas, K. Z. AU - Tansarli, G. S. AU - Rafailidis, P. I. AU - Falagas, M. E. PY - 2012 DA - 2012// TI - Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis JO - J Antimicrob Chemother VL - 67 UR - https://doi.org/10.1093/jac/dks301 DO - 10.1093/jac/dks301 ID - Vardakas2012 ER - TY - JOUR AU - Pitout, J. D. AU - Le, P. G. AU - Moore, K. L. AU - Church, D. L. AU - Gregson, D. B. PY - 2010 DA - 2010// TI - Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and JO - Infectious Diseases VL - 16 ID - Pitout2010 ER - TY - JOUR AU - Sheng, W. -. H. AU - Badal, R. E. AU - Hsueh, P. -. R. PY - 2013 DA - 2013// TI - Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among enterobacteriaceae isolates causing intra-abdominal infections in the Asia-pacific region: results of the study for monitoring antimicrobial resistance trends (SMART) JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.00971-12 DO - 10.1128/AAC.00971-12 ID - Sheng2013 ER - TY - JOUR AU - Koh, T. H. PY - 2008 DA - 2008// TI - Gram-negative resistance in Singapore: a historical perspective JO - Ann Acad Med Singap VL - 37 ID - Koh2008 ER - TY - JOUR AU - Koh, T. H. AU - Cao, D. AU - Shan, Q. Y. AU - Bacon, A. AU - Hsu, L. Y. AU - Ooi, E. E. PY - 2013 DA - 2013// TI - Acquired carbapenemases in enterobactericeae in Singapore, 1996–2012 JO - Pathology VL - 45 UR - https://doi.org/10.1097/PAT.0b013e3283650b1e DO - 10.1097/PAT.0b013e3283650b1e ID - Koh2013 ER - TY - STD TI - Gutiérrez-Gutiérrez B, Salamanca E, Pérez-Galera S, Bonomo R, Carmeli Y, Paterson D et al. Assessment of betalactam/beta-lactamase inhibitor combinations for the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: The INCREMENT Project. Program and abstracts of the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract K-1041). Washington, DC: American Society for Microbiology, 2014. ID - ref33 ER - TY - JOUR AU - Deresinski, S. PY - 2013 DA - 2013// TI - In the literature. Piperacillin-tazobactam and extended-spectrum beta-lactamase--producing Escherichia coli JO - Clin Infect Dis VL - 57 UR - https://doi.org/10.1093/cid/cit623 DO - 10.1093/cid/cit623 ID - Deresinski2013 ER - TY - STD TI - Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015. doi:10.1093/cid/civ003. ID - ref35 ER -